Marc L. Reitman, M.D., Ph.D.

Senior Investigator

Diabetes, Endocrinology, and Obesity Branch

NIDDK

Building 10-CRC, Room 5-5940
10 Center Drive
Bethesda, MD 20814

301-496-6442

marc.reitman@nih.gov

Research Topics

Research Goal

Obesity has reached pandemic proportions and treatment is rarely successful for the long term.  We believe that by elucidating the underlying physiology, novel and effective anti-obesity therapies will be discovered.  Effective obesity treatment will also stem the epidemic of type 2 diabetes mellitus.

Current Research

I am broadly interested in a mechanistic and translational understanding of diabetes, energy homeostasis, and obesity.  My particular interests include studying mouse genetics and pharmacology, using mouse models to understand metabolic rate regulation, body temperature regulation and the role of BRS-3 (bombesin receptor subtype-3), and exploring drug treatments for obesity.  One current project involves dissecting the neuroscience of how BRS-3 regulates metabolic rate, body temperature, and blood pressure.  Another project explores how to improve the use of mice to evaluate candidate treatments for human obesity.  A third interest is the role of brown adipose tissue and uncoupling in mouse and human thermal biology and body weight regulation.​

Applying our Research

By studying the mechanisms involved in energy homeostasis, we should gain knowledge that will lead to advancements in the treatment of diabetes and obesity.

Biography

  • Senior Investigator and Branch Chief, NIDDK, NIH, 2011-present
  • Director, Clinical Research; Director Obesity and Metabolic Research, Merck Research Laboratories, 2002-2011
  • Fellow; Investigator; Senior Investigator, NIDDK, NIH, 1986-2002
  • Residency in Internal Medicine, Columbia-Presbyterian Hospital, 1983-1986
  • M.D., Ph.D., Washington University, 1983
  • B.S., Massachusetts Institute of Technology, 1977

Selected Publications

  1. Lute B, Jou W, Lateef DM, Goldgof M, Xiao C, Piñol RA, Kravitz AV, Miller NR, Huang YG, Girardet C, Butler AA, Gavrilova O, Reitman ML. Biphasic effect of melanocortin agonists on metabolic rate and body temperature. Cell Metab. 2014;20(2):333-45.

  2. Xiao C, Reitman ML. Bombesin-Like Receptor 3: Physiology of a Functional Orphan. Trends Endocrinol Metab. 2016;27(9):603-5.

  3. Lateef DM, Xiao C, Brychta RJ, Diedrich A, Schnermann J, Reitman ML. Bombesin-like receptor 3 regulates blood pressure and heart rate via a central sympathetic mechanism. Am J Physiol Heart Circ Physiol. 2016;310(7):H891-8.

  4. Abreu-Vieira G, Xiao C, Gavrilova O, Reitman ML. Integration of body temperature into the analysis of energy expenditure in the mouse. Mol Metab. 2015;4(6):461-70.

  5. Carlin JL, Jain S, Gizewski E, Wan TC, Tosh DK, Xiao C, Auchampach JA, Jacobson KA, Gavrilova O, Reitman ML. Hypothermia in mouse is caused by adenosine A<sub>1</sub> and A<sub>3</sub> receptor agonists and AMP via three distinct mechanisms. Neuropharmacology. 2017;114:101-113.


This page was last updated on May 17th, 2016